← Leaderboards
Hanny T Al-Samkari
Massachusetts General Hospital
$799,200
Attributed
$799,200
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $199.8K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$799,200 · 1
By mechanism
K23$799,200 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jonghan Kim$7,685,146
- Hak Soo Choi$7,452,919
- Marie Demay$19,218,520
- David A Drew$792,600
- Sam Sunghyun Yoon$2,703,621
Others in their field
Other Rising Stars on “Affect”
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Brian Todd Schaneberg · Illinois Institute Of Technology$13,469,813
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
AffectEnvironmentAngiogenesisAngiogenesis InhibitorsAdultBevacizumabBiological MarkersBlood Coagulation DisordersBlood TransfusionCareer DevelopmentAnemiaCharacteristicsChronicClinical InvestigatorClinical TrialsControl GroupsCorrelative StudyDependenceDesignDevelopment PlansDoseDrug RepurposingCaringEpistaxis
Grant awards (4)
Antiangiogenic Therapy to Reduce Bleeding and Improve Health-Related Quality of Life in Hereditary Hemorrhagic Telangiectasia$199,800
K23 · FY2025 · HL · contact PI
Antiangiogenic Therapy to Reduce Bleeding and Improve Health-Related Quality of Life in Hereditary Hemorrhagic Telangiectasia$199,800
K23 · FY2024 · HL · contact PI
Antiangiogenic Therapy to Reduce Bleeding and Improve Health-Related Quality of Life in Hereditary Hemorrhagic Telangiectasia$199,800
K23 · FY2023 · HL · contact PI
Antiangiogenic Therapy to Reduce Bleeding and Improve Health-Related Quality of Life in Hereditary Hemorrhagic Telangiectasia$199,800
K23 · FY2022 · HL · contact PI